Moderna Burns Cash, Suffers Fresh Vaccine Setback
Moderna (MRNA) Q2 Earnings: Beat estimates with $145M in sales and a $1.97 EPS loss. Reaffirms 2026 sales guidance.
Moderna made more money than expected this quarter, but it's still losing money overall and burning through its savings. When a company loses money while spending fast, watch whether their new products can start making profits soon.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.